Drugs / D5884
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02209766 | Aug → Nov 2014 | — | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | D5884 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02209766 ↗ |
| Known as | Omega-3-carboxylic Acids | “A Ph1 Study in Healthy Male Japanese and Caucasian After Single and Multiple Doses of D5884(Omega-3-carboxylic Acids)” NCT02209766 ↗ |
| Route | Oral | “D5884 capsule, Per oral(po)” NCT02209766 ↗ |